Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Taphoorn MJ"" wg kryterium: Autor


Tytuł :
Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
Autorzy :
Maringwa JT
Quinten C
King M
Ringash J
Osoba D
Coens C
Martinelli F
Vercauteren J
Cleeland CS
Flechtner H
Gotay C
Greimel E
Taphoorn MJ
Reeve BB
Koch JS
Weis J
Smit EF
van Meerbeeck JP
Bottomley A
EORTC PROBE project and the Lung Cancer Group
Pokaż więcej
Źródło :
Supportive Care in Cancer; Nov2011, Vol. 19 Issue 11, p1753-1760, 8p
Czasopismo naukowe
Tytuł :
Examining the relationships among health-related quality-of-life indicators in cancer patients participating in clinical trials: a pooled study of baseline EORTC QLQ-C30 data.
Autorzy :
Martinelli F
Quinten C
Maringwa JT
Coens C
Vercauteren J
Cleeland CS
Flechtner H
Gotay C
Greimel E
King M
Mendoza T
Osoba D
Reeve BB
Ringash J
Koch JS
Shi Q
Taphoorn MJ
Weis J
Bottomley A
European Organisation for Research and Treatment of Cancer Clinical Groups
Pokaż więcej
Źródło :
Expert Review of Pharmacoeconomics & Outcomes Research; Oct2011, Vol. 11 Issue 5, p587-599, 13p
Czasopismo naukowe
Tytuł :
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.
Autorzy :
van den Bent MJ
Dubbink HJ
Sanson M
van der Lee-Haarloo CR
Hegi M
Jeuken JW
Ibdaih A
Brandes AA
Taphoorn MJ
Frenay M
Lacombe D
Gorlia T
Dinjens WN
Kros JM
van den Bent, Martin J
Dubbink, Hendrikus J
Sanson, Marc
van der Lee-Haarloo, Cathleen R
Hegi, Monika
Jeuken, Judith W M
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 12/10/2009, Vol. 27 Issue 35, p5881-5886, 6p
Czasopismo naukowe
Tytuł :
Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.
Autorzy :
van den Bent MJ
Brandes AA
Rampling R
Kouwenhoven MC
Kros JM
Carpentier AF
Clement PM
Frenay M
Campone M
Baurain JF
Armand JP
Taphoorn MJ
Tosoni A
Kletzl H
Klughammer B
Lacombe D
Gorlia T
van den Bent, Martin J
Brandes, Alba A
Rampling, Roy
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 3/10/2009, Vol. 27 Issue 8, p1268-1274, 7p
Czasopismo naukowe
Tytuł :
Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
Autorzy :
Mauer ME
Taphoorn MJ
Bottomley A
Coens C
Efficace F
Sanson M
Brandes AA
van der Rijt CC
Bernsen HJ
Frénay M
Tijssen CC
Lacombe D
van den Bent MJ
EORTC Brain Cancer Group
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 12/20/2007, Vol. 25 Issue 36, p5731-5737, 7p
Czasopismo naukowe
Tytuł :
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial.
Autorzy :
Taphoorn MJ
van den Bent MJ
Mauer ME
Coens C
Delattre JY
Brandes AA
Sillevis Smitt PA
Bernsen HJ
Frénay M
Tijssen CC
Lacombe D
Allgeier A
Bottomley A
European Organisation for Research and Treatment of Cancer
Pokaż więcej
Źródło :
Journal of Clinical Oncology; 12/20/2007, Vol. 25 Issue 36, p5723-5730, 8p
Czasopismo naukowe
Tytuł :
Patient-oriented outcome measures in brain tumor patients: catching up after a slow start.
Autorzy :
Taphoorn MJ
Pokaż więcej
Źródło :
Expert Review of Pharmacoeconomics & Outcomes Research; Feb2012, Vol. 12 Issue 1, p1-3, 3p
Czasopismo naukowe
Tytuł :
Bandolier's little book of pain.
Autorzy :
Taphoorn MJ
Pokaż więcej
Źródło :
European Journal of Cancer Care; Sep2004, Vol. 13 Issue 4, p393-393, 1p
Czasopismo naukowe
Tytuł :
Retention rates of antiepileptic drugs in glioma patients: the most appropriate outcome.
Autorzy :
van der Meer PB; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Fiocco M; Department of Biomedical Data Sciences, Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.
Taphoorn MJ; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Koekkoek JA; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, The Netherlands.
Pokaż więcej
Źródło :
CNS oncology [CNS Oncol] 2020 Jun; Vol. 9 (2), pp. CNS53. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Prediagnostic presentations of glioma in primary care: a case-control study.
Autorzy :
Peeters MC; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Dirven L; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Burg. Banninglaan, 2262 BA Leidschendam, The Netherlands.
Koekkoek JA; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Burg. Banninglaan, 2262 BA Leidschendam, The Netherlands.
Numans ME; Department of Public Health & Primary Care, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
Taphoorn MJ; Department of Neurology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Neurology, Haaglanden Medical Center, Burg. Banninglaan, 2262 BA Leidschendam, The Netherlands.
Pokaż więcej
Źródło :
CNS oncology [CNS Oncol] 2019 Nov 01; Vol. 8 (3), pp. CNS44. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Journal Article
MeSH Terms :
Central Nervous System Neoplasms/*diagnosis
Glioma/*diagnosis
Adult ; Aged ; Case-Control Studies ; Central Nervous System Neoplasms/epidemiology ; Central Nervous System Neoplasms/psychology ; Diagnosis, Differential ; Fear ; Female ; Glioma/epidemiology ; Glioma/psychology ; Humans ; Male ; Middle Aged ; Mood Disorders/etiology ; Prevalence ; Primary Health Care/methods ; Prognosis
Czasopismo naukowe
Tytuł :
Visual inspection of MR relative cerebral blood volume maps has limited value for distinguishing progression from pseudoprogression in glioblastoma multiforme patients.
Autorzy :
Kerkhof M; Department of Neurology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Tans PL; Department of Neurology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Hagenbeek RE; Department of Radiology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Lycklama À Nijeholt GJ; Department of Radiology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Holla FK; Department of Neurology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Postma TJ; Department of Neurology, VU University Medical Center, Amsterdam 1007 MB, The Netherlands.
Straathof CS; Department of Neurology, Leiden University Medical Center, Leiden 2300 RA, The Netherlands.
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden 2300 RA, The Netherlands.
Taphoorn MJ; Department of Neurology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.; Department of Neurology, Leiden University Medical Center, Leiden 2300 RA, The Netherlands.
Vos MJ; Department of Neurology, Haaglanden Medical Center, The Hague 2501 CK, The Netherlands.
Pokaż więcej
Źródło :
CNS oncology [CNS Oncol] 2017 Oct; Vol. 6 (4), pp. 297-306. Date of Electronic Publication: 2017 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Brain Neoplasms/*diagnostic imaging
Glioblastoma/*diagnostic imaging
Magnetic Resonance Imaging/*methods
Adult ; Aged ; Brain Neoplasms/pathology ; Cerebral Blood Volume ; Disease Progression ; Female ; Glioblastoma/pathology ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Development of an item bank for computerized adaptive testing of self-reported cognitive difficulty in cancer patients.
Autorzy :
Dirven L; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Taphoorn MJ; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Groenvold M; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Habets EJ; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Aaronson NK; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Conroy T; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Reijneveld JC; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Young T; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Petersen MA; Department of Neurology, Leiden University Medical Center, PO BOX 9600, 2300 RC Leiden, the Netherlands (L.D., M.J.B.T.); Department of Neurology, Medical Center Haaglanden, PO BOX 432, 2501 CK The Hague, the Netherlands (M.J.B.T., E.J.J.H.); Department of Palliative Medicine, Bispebjerg Hospital, Bakke 23 DK-2400 Copenhagen NV, Denmark(M.G., M.A.P.); Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, PO BOX 90203, 1006 BE Amsterdam, the Netherlands (N.K.A.); Medical Oncology Department, Institut de Cancérologie de Lorraine 6, Avenue de Bourgogne - CS 30519 54519 Vandoeuvre-lès-Nancy Cedex, France (T.C.); Department of Neurology, VU University Medical Center, PO BOX 7057, 1007 MB Amsterdam, the Netherlands (J.C.R.); Department of Neurology, Academic Medical Center, PO BOX 22660, 1100 DD Amsterdam, the Netherlands (J.C.R.); Lynda Jackson Macmillan Centre, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN, UK (T.Y.).
Pokaż więcej
Corporate Authors :
EORTC Quality of Life Group
Źródło :
Neuro-oncology practice [Neurooncol Pract] 2017 Sep; Vol. 4 (3), pp. 189-196. Date of Electronic Publication: 2017 Jan 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
Autorzy :
Ediebah DE; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Reijneveld JC; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Taphoorn MJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.
Coens C; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Zikos E; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Heimans JJ; Department of Neurology, VU University Medical Center, Amsterdam, The Netherlands.
Bottomley A; Quality of Life Department, European Organisation for Research and Treatment of Cancer (EORTC), Brussels, Belgium.
Klein M; Department of Medical Psychology - B7D349, VU University Medical Center, Van der Boechorststraat 7, 1081 BT, Amsterdam, The Netherlands. .
Pokaż więcej
Corporate Authors :
EORTC Quality of Life Department and Patient Reported Outcome and Behavioral Evidence (PROBE)
Źródło :
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2017 Apr; Vol. 26 (4), pp. 869-880. Date of Electronic Publication: 2016 Oct 15.
Typ publikacji :
Journal Article
MeSH Terms :
Quality of Life*
Brain Neoplasms/*complications
Cognitive Dysfunction/*psychology
Glioma/*complications
Adult ; Brain Neoplasms/pathology ; Cognitive Dysfunction/complications ; Cross-Sectional Studies ; Data Interpretation, Statistical ; Female ; Glioma/pathology ; Humans ; Male ; Neoplasm Grading ; Netherlands ; Proxy ; Self Report
Czasopismo naukowe
Tytuł :
Development of a questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumors: a pilot study.
Autorzy :
Oort Q; Department of Neurology and Brain Tumor Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands. .
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
Meijer W; Department of Neurology and Brain Tumor Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
Sikkes SA; Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.; Alzheimer Center, VU University Medical Center, Amsterdam, The Netherlands.
Uitdehaag BM; Department of Neurology and Brain Tumor Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.
Reijneveld JC; Department of Neurology and Brain Tumor Center Amsterdam, VU University Medical Center, PO Box 7057, 1007 MB, Amsterdam, The Netherlands.; Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands.
Taphoorn MJ; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.
Pokaż więcej
Źródło :
Journal of neuro-oncology [J Neurooncol] 2017 Mar; Vol. 132 (1), pp. 145-153. Date of Electronic Publication: 2017 Feb 01.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Activities of Daily Living*
Neuropsychological Tests*
Surveys and Questionnaires*
Brain Neoplasms/*psychology
Adult ; Aged ; Female ; Glioma/psychology ; Humans ; Male ; Middle Aged ; Pilot Projects
Czasopismo naukowe
Tytuł :
The withdrawal of antiepileptic drugs in patients with low-grade and anaplastic glioma.
Autorzy :
Koekkoek JA; a Department of Neurology , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Neurology , Medical Center Haaglanden , The Hague , The Netherlands.
Dirven L; a Department of Neurology , Leiden University Medical Center , Leiden , The Netherlands.
Taphoorn MJ; a Department of Neurology , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Neurology , Medical Center Haaglanden , The Hague , The Netherlands.
Pokaż więcej
Źródło :
Expert review of neurotherapeutics [Expert Rev Neurother] 2017 Feb; Vol. 17 (2), pp. 193-202. Date of Electronic Publication: 2016 Aug 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Anticonvulsants/*therapeutic use
Antineoplastic Agents/*therapeutic use
Epilepsy/*drug therapy
Glioma/*drug therapy
Drug Interactions ; Epilepsy/complications ; Glioma/complications ; Humans ; Recurrence ; Seizures/drug therapy
Czasopismo naukowe
Tytuł :
Advance Care Planning in Glioblastoma Patients.
Autorzy :
Fritz L; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. .
Dirven L; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
Reijneveld JC; Department of Neurology, VU University Medical Center, P.O. BOX 7057, 1007 MB Amsterdam, The Netherlands. .; Department of Neurology, Academic Medical Center, P.O. BOX 22660, 1100 DD Amsterdam, The Netherlands. .
Koekkoek JA; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. .; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
Stiggelbout AM; Department of Medical Decision Making/Quality of Care, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. .
Pasman HR; Department of Public and Occupational Health, VU University Medical Center, P.O. BOX 7057, 1007 MB Amsterdam, The Netherlands. .
Taphoorn MJ; Department of Neurology, Haaglanden Medical Center, P.O. BOX 432, 2501 CK The Hague, The Netherlands. m.j.b.taphoorn@lumc.nl.; Department of Neurology, Leiden University Medical Center, P.O. BOX 9600, 2300 RC Leiden, The Netherlands. m.j.b.taphoorn@lumc.nl.
Pokaż więcej
Źródło :
Cancers [Cancers (Basel)] 2016 Nov 08; Vol. 8 (11). Date of Electronic Publication: 2016 Nov 08.
Typ publikacji :
Review; Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies